TechTarget Launches Prospect-Level Purchase Intent Data for Healthcare in Latest Release of its Priority Engine Platform


TechTarget, Inc., the industry pioneer in prospect-level intent data and services for B2B technology purchases, today announced the launch of Priority EngineTM for Healthcare to assist sales and marketing teams in utilising their prospect-level intent data to generate more opportunities and pipeline with leading organisations in the healthcare sector. In a single SaaS solution that delivers tailored insights specifically for B2B organisations targeting healthcare, this new offering gives direct access to the combined opt-in audience of healthcare tech and business decision-makers from TechTarget and Xtelligent Healthcare MediaTM (acquired in August 2021).

“Being able to provide our customers with 1st party intent data on the largest healthcare technology and information audience on the web is a true game changer in our industry”, “Sales and marketing teams will now have direct access to entire healthcare buying teams, including Clinicians, Line of Business and IT Decision-Makers, to find more opportunities and accelerate technology deals.”

Sean Brooks, Co-Founder, Xtelligent Healthcare Media

These updated improvements:

  • To improve visibility into and engagement opportunities with full buying teams across the entire interconnected healthcare ecosystem, including: Providers, Health Systems, Payers, Pharmaceuticals, Life Sciences, Accountable Care Organizations, and Federal/State Healthcare Agencies, Priority Engine has added thousands of new accounts and more than 400,000 new contacts. This encompasses 90 percent of the US health systems.
  • Provide more access to business decision-makers who have opted in and are directly involved in procuring healthcare. More than 70% of the readership of Xtelligent Healthcare Media consists of business and finance executives and clinicians who play a crucial role in the increasingly complex acquisitions of healthcare technology.
  • Assist marketing and sales teams in converting more opportunities and accelerating deals with better informed, personalised, and timely outreach by providing highly relevant, customised intent insights on topical interests, content consumption, and vendor engagement of healthcare technology buyers at both the account and prospect-level.

The methodology used to create and offer TechTarget purchase intent intelligence to B2B IT marketing and sales professionals makes it particularly potent. The amount of original editorial and vendor content across hundreds of distinct IT and business issues across TechTarget’s network of over 150 technology-specific websites and 1,125 channels is what makes the actionable insights within the Priority Engine platform possible. We offer the knowledge and resources to support each team member’s research and decision-making as enterprise technology buying teams expand and purchases become more difficult.

TechTarget’s customers are successful in a relevant adjacent industry with high degrees of purchasing complexity and buying dynamics thanks to Priority Engine for Healthcare.

“By expanding the amount of permission-based, relevant 1st party purchase intent data our customers have access to and delivering a full suite of marketing, sales and go-to-market services to engage real buyers, we help companies of all sizes achieve better results at scale in this market”, “As a leader in coverage of B2B enterprise tech for more than 20 years – combined with working very closely with our almost 3,000 customers – TechTarget has unique visibility into the buying dynamics across every major sector of the market. Our experience positions us well to bring our model to adjacent vertical markets with similar attributes to enterprise B2B tech – long/complex-sales cycles, large purchases, multiple members of the buying team and a strong need for 1st party data to enable marketers and sellers – just as we have done in Healthcare.”

Michael Cotoia, CEO, TechTarget

Next Post

Hansa Biopharma achieves Great Place to Work certification for the third consecutive year

The Great Place to Work institute, an impartial and widely respected authority on workplace culture, has certified Hansa Biopharma AB as a Great Place to Work 2022, the pioneer in enzyme technology for rare immunological disorders. Hansa has already been certified three times in a row. The Great Place to […]